Fereshteh Zeinab, Fathi Mohammadhossein, Bagri Akbar, Boccaccini Aldo R
Institute of Biomaterials, Department of Materials Science and Engineering, University of Erlangen-Nuremberg, Cauerstrasse 6, 91058 Erlangen, Germany; Institute of Science, High Technology, and Environmental Sciences, Graduate University of Advanced Technology, 76315117 Kerman, Iran; Biomaterials Research Group, Department of Materials Engineering, Isfahan University of Technology, Isfahan 8415683111, Iran.
Biomaterials Research Group, Department of Materials Engineering, Isfahan University of Technology, Isfahan 8415683111, Iran; Dental Materials Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:613-622. doi: 10.1016/j.msec.2016.06.009. Epub 2016 Jun 8.
A novel type of drug-delivery scaffold based on poly(ε-caprolactone) (PCL) and zein blends was prepared by improved unidirectional freeze-drying. Scaffolds with tube-like pore structure and high porosity, up to 89%, were obtained by adjusting the concentration of the PCL and zein solutions. Characters of the prepared scaffolds, such as microstructural, porosity, and compressive strength, were evaluated. The hydrophilicity and the degradability of the composite films were investigated in contact with phosphate buffer saline (PBS). It was found that the presence of zein accelerates the degradation rate of the scaffolds in the period time of investigation (28days). The results showed an acceptable way for controlling the in vitro degradation behavior of PCL composite scaffolds by adapting the concentration of zein. In vitro protein release and degradation results revealed that the absolute weight loss of the PCL/zein scaffolds exhibited an increasing trend by increasing the amount of zein concentration in the scaffolds. The drug delivery capability of the scaffolds was tested using tetracycline hydrochloride (TCH). Sustained release of the drug was obtained, and it was found that the proportion of zein in the scaffold had a great impact on the drug release kinetics. The results demonstrated the potential of the PCL/zein biocomposite scaffolds as a suitable candidate in tissue engineering strategies for bone defect treatment.
通过改进的单向冷冻干燥法制备了一种基于聚(ε-己内酯)(PCL)和玉米醇溶蛋白共混物的新型药物递送支架。通过调节PCL和玉米醇溶蛋白溶液的浓度,获得了具有管状孔结构和高达89%高孔隙率的支架。对制备的支架的微观结构、孔隙率和抗压强度等特性进行了评估。研究了复合膜与磷酸盐缓冲盐水(PBS)接触时的亲水性和降解性。发现在研究期间(28天),玉米醇溶蛋白的存在加速了支架的降解速率。结果表明,通过调整玉米醇溶蛋白的浓度,是控制PCL复合支架体外降解行为的一种可行方法。体外蛋白质释放和降解结果表明,PCL/玉米醇溶蛋白支架的绝对失重随着支架中玉米醇溶蛋白浓度的增加而呈上升趋势。使用盐酸四环素(TCH)测试了支架的药物递送能力。实现了药物的持续释放,并且发现支架中玉米醇溶蛋白的比例对药物释放动力学有很大影响。结果证明了PCL/玉米醇溶蛋白生物复合支架作为骨缺损治疗组织工程策略中合适候选材料的潜力。